ClinConnect ClinConnect Logo
Search / Trial NCT03791775

Efficacy and Safety of Polidocanol Foam 3% in the Treatment of II Degree Hemorrhoidal Disease

Launched by SOCIETA ITALIANA DI CHIRURGIA COLORETTALE · Jan 1, 2019

Trial Information

Current as of June 12, 2025

Completed

Keywords

Hemorrhoids Sclerotherapy Polidocanol 3% Non Surgical Treatments

ClinConnect Summary

As reported by the guidelines of the Italian Society of Colorectal Surgery, in case of failure of conservative therapies the most common outpatient treatments for first- and second-degree Hemorrhoidal Disease (HD) are rubber band ligation and sclerotherapy.

Sclerotherapy causes an inflammatory reaction with local sclerosis of the submucosal tissue and a consequent fixation of the haemorrhoidal tissue to the underlying tissue. Moreover, the effect of sclerosing solutions is that of making vascular damage via producing endothelial injury.

A 100% improvement in bleeding was reported in patie...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patients above 18 and below 75 years of age with a confirmed diagnosis of second-degree HD (proctological examination, proctoscopy and, if required, colonoscopy)
  • 2. Patients who report persistent perianal bleeding as a typical symptom of second-degree HD
  • 3. Informed consent from each patient must be obtained
  • 4. Participating centres will be asked to confirm that they have gained formal approval at their site
  • Exclusion Criteria:
  • 1. Previous anal surgical procedures
  • 2. Previous sclerotherapy or rubber band ligation in the last 12 months
  • 3. Positive pregnancy test
  • 4. Patients with inability to return for postoperative control visits, to sign the informed consent or to fill out the required clinical diary
  • 5. Breast-feeding
  • 6. Known allergy to polidocanol
  • 7. Acute perianal thrombosis
  • 8. Anal fistula
  • 9. Anal fissure
  • 10. Proctitis
  • 11. Fecal incontinence
  • 12. Coagulation disorders
  • 13. Anticoagulant therapy
  • 14. Known HBV, HCV and HIV infection
  • 15. Acite Crohn's disease or Ulcerative colitis
  • 16. Diabetes mellitus I and II
  • 17. COPD
  • 18. Any kind of tumour
  • 19. Previous pelvic radiotherapy

About Societa Italiana Di Chirurgia Colorettale

The Società Italiana di Chirurgia Colorettale (SICCR) is a premier professional organization dedicated to advancing the field of colorectal surgery in Italy. Comprising a network of leading surgeons and healthcare professionals, SICCR focuses on promoting innovative research, enhancing surgical techniques, and improving patient outcomes through rigorous clinical trials and collaborative initiatives. The society plays a crucial role in setting clinical guidelines, providing educational resources, and fostering interdisciplinary partnerships to enhance the quality of care for patients with colorectal conditions. With a commitment to excellence, SICCR aims to drive the evolution of colorectal surgery while ensuring the highest standards of safety and efficacy in clinical practice.

Locations

Catanzaro, , Italy

Patients applied

0 patients applied

Trial Officials

Gaetano Gallo, MD

Principal Investigator

Department of Medical and Surgical Sciences, University of Catanzaro, Catanzaro 88100, Italy

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials